The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Here's a roundup of top developments in the biotech space over the last 24 hours.
Chardan Capital Maintains Buy on LogicBio Therapeutics, Lowers Price Target to $16
Chardan Capital analyst Geulah Livshits maintains LogicBio Therapeutics (NASDAQ:LOGC) with a Buy and lowers the price target from $20 to $16.
LogicBio Therapeutics Provides Business Updates
LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial and development pipeline, and announced the appointment
46 Biggest Movers From Yesterday
Gainers
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
LogicBio Therapeutics Q3 EPS $(0.31) Up From $(0.34) YoY
LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.31) per share. This is a 8.82 percent increase over losses of $(0.34) per share from the same period last year.
LogicBio Therapeutics To Present Data On GeneRide At European Society Of Gene And Cell Therapy (ESGCT) Virtual Congress 2021
LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today is slated to present new preclinical data on its GeneRide™ platform at the European Society of Gene and Cell Therapy
LogicBio Therapeutics Announces Early Clinical Trial Results From Phase 1/2 SUNRISE Trial Demonstrating ‘measurable levels of albumin-2A’
LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced clinical trial results demonstrating the first-ever in vivo genome editing in children. Early data from
LogicBio Therapeutics Q2 EPS $(0.33) Up From $(0.35) YoY, Sales $802.00M Up From $965.00K YoY
LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.33) per share. This is a 5.71 percent increase over losses of $(0.35) per share from the same period last year. The company reported $802.00 million
